Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.
about
Optimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo ApplicationsCrystallographic Fragment Screening and Structure-Based Optimization Yields a New Class of Influenza Endonuclease InhibitorsReverse Genetics Approaches for the Development of Influenza VaccinesThe specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?Replication-competent fluorescent-expressing influenza B virusNonreplicating influenza A virus vaccines confer broad protection against lethal challengeMulti-Modal Imaging with a Toolbox of Influenza A Reporter VirusesInfluenza A virus attenuation by codon deoptimization of the NS gene for vaccine developmentInfluenza A and B virus intertypic reassortment through compatible viral packaging signals.Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunityGenetically engineered, biarsenically labeled influenza virus allows visualization of viral NS1 protein in living cells.Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodies.Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segmentMaternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.The taking of the cytoskeleton one two three: how viruses utilize the cytoskeleton during egress.Replication-competent influenza A viruses expressing a red fluorescent protein.Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.Taming influenza viruses.A Conserved Secondary Structural Element in the Coding Region of the Influenza A Virus Nucleoprotein (NP) mRNA Is Important for the Regulation of Viral Proliferation.Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.Attenuated influenza virus construct with enhanced hemagglutinin protein expressionReplication-incompetent influenza A viruses that stably express a foreign geneIdentification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virusD471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesisEngineering influenza viral vectorsProtection against lethal influenza with a viral mimic.Visualizing influenza virus infection in living mice.Exploration of binary virus-host interactions using an infectious protein complementation assayHighly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread.Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation.Reverse Genetics Approaches to Control Arenavirus.A versatile RNA vector for delivery of coding and noncoding RNAs.Development and applications of single-cycle infectious influenza A virus (sciIAV).Epistatic Interactions within the Influenza A Virus Polymerase Complex Mediate Mutagen Resistance and Replication Fidelity.A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses.Reverse Genetics of Influenza B Viruses.Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle.Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.
P2860
Q27301941-A3CD656A-07C3-4D3F-8E95-B1B0FD29B66BQ27679805-0D153995-9AE2-4802-9458-C6FCA70313F5Q28076140-50BB93D2-D31C-42BB-AEE5-8C4E485647B3Q28251512-438500ED-EA20-4DD1-9BE2-8CF80832823FQ28387786-7F376C24-42E7-4A23-B15C-431B1375DA68Q28392109-8D620999-8610-4E49-8760-2C48E87A5340Q28393104-D457569C-6459-4B22-B765-8A9ADAA61848Q28395006-FF35A9C9-042E-4531-8E8C-E1F9935EB3B8Q30364518-9E404604-0774-4364-BB0A-E30FCD469C90Q30375314-6E657E85-C6B6-4974-8132-0BA00C9E9725Q30421682-68215E8B-9843-4043-8569-C145718641FBQ30495310-BCF73DBD-A938-4609-B2D6-0C6785AE2D0AQ33683079-05396C10-A303-4EFA-BE99-CDF301AFE716Q34261441-3179AE31-2D22-45FB-844D-5EB68BEB58CCQ34296134-6B79D782-F932-4BE2-8B9D-4B21F8623F8AQ34566313-1CD957F1-1AAE-44FF-99AF-832837ADC84AQ34629230-3F93E971-770D-4D89-BDE5-5543826556A5Q35071285-645A8C7F-12EB-4BA3-BFC3-4FC400C1A80FQ35408014-5CB60AE8-5D75-48D1-BA84-C7817977F346Q35571169-706967B5-A9CD-4AA8-9611-29E654A7C6DCQ35815859-20982FC9-9DC7-4C7A-B5E6-EC131BFC845AQ35869278-A09E4290-1B77-4920-A292-24BEC4F2F533Q35943504-A5FE6EA0-BAA4-4397-8AB0-252066AF6C80Q35961330-93D0DF8E-083A-4F4D-91CD-673700285F9EQ36018581-ED9C6FD9-C41F-4E79-A628-F51C8C6DB789Q36395857-95366EF5-2E59-4594-A77C-889BF69EC84BQ36591871-214FFB44-EEA9-485D-A8B2-06E9AD0802D0Q37036766-C667D052-4394-410E-94B7-840A6CD1456CQ37186373-835667EF-A0DB-4E23-A8B3-79A84C061EF9Q37214687-58CE9927-B7B1-4CB6-8638-B06205090280Q37336673-CAC96570-6E56-49B3-9ABF-8004BA7DAE00Q37540505-D9468005-F5E7-44DF-9721-9AEAD5AAA6A7Q37543755-18383D50-EC00-4819-91AA-9651D4064AE6Q37547028-6E62860C-4C30-4D2E-B5F9-B8AB64BC1F46Q38556537-E4A1F9C9-92D0-4D44-AA14-033D583B83D0Q38621087-7E8EA1B0-1952-418E-AC4A-5F0A5C599064Q38734385-DA25F411-B020-4629-82B7-AB3B5AF7DA34Q39309001-68411DBE-5099-4F2A-8E89-5A3D11523249Q39437773-029D6E9C-F448-4B41-89BD-226A8F6699E9Q39625153-50DD3ADF-8E32-4240-BC57-38C43E9F791B
P2860
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hemagglutinin-pseudotyped gree ...... virus neutralizing antibodies.
@ast
Hemagglutinin-pseudotyped gree ...... virus neutralizing antibodies.
@en
type
label
Hemagglutinin-pseudotyped gree ...... virus neutralizing antibodies.
@ast
Hemagglutinin-pseudotyped gree ...... virus neutralizing antibodies.
@en
prefLabel
Hemagglutinin-pseudotyped gree ...... virus neutralizing antibodies.
@ast
Hemagglutinin-pseudotyped gree ...... virus neutralizing antibodies.
@en
P2093
P2860
P50
P356
P1433
P1476
Hemagglutinin-pseudotyped gree ...... virus neutralizing antibodies.
@en
P2093
John Steel
Luis Martínez-Sobrido
Richard Cadagan
Thomas M Moran
P2860
P304
P356
10.1128/JVI.01433-09
P577
2009-11-25T00:00:00Z